Fortrea to Participate in Jefferies Global Healthcare Conference

Fortrea (FTRE) will participate in the Jefferies Global Healthcare Conference in London on November 17, 2026, with a fireside chat and investor meetings.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Fortrea (FTRE) will participate in the Jefferies Global Healthcare Conference in London on November 17, 2026, with a fireside chat and investor meetings.

CEO Anshul Thakral, CFO Jason Knoblauch and SVP of Investor Relations Tracy Krumme will attend. The fireside chat runs from 8:30–8:55 AM EST, or 1:30–1:55 PM GMT. A live webcast and video replay will be available through the Events section of Fortrea’s investor relations website.

Key Terms

cro

1 terms

cro technical

"contract research organization (“CRO”)"

CRO stands for Contract Research Organization, a company that helps pharmaceutical and biotech firms manage and carry out clinical trials to test new medicines. For investors, CROs are important because they enable drug companies to develop new treatments more efficiently, potentially accelerating the path to market and affecting the company's growth prospects and success.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/27/2026 - 07:00 AM EDT

DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations Tracy Krumme will participate in the following conference:

Jefferies Global Healthcare Conference (London, U.K.)
Date: Tuesday, November 17, 2026
Format: Fireside Chat & 1x1 and Group Meetings
Time: 8:30 AM – 8:55 AM EST | 1:30 PM – 1:55 PM GMT
Webcast: FTRE Jefferies Webcast

The live webcast and video replay of the Jefferies fireside chat will be accessible through the “Events” section of Fortrea’s Investor Relations website. Investors interested in meeting with management should contact their banking representatives.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.

Fortrea Contacts

Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com